EFPIA 'did not lobby' for EC medicines move
This article was originally published in SRA
As pressure grows for a rethink of controversial plans to place pharmaceutical and medical device policy under the European Commission's industry directorate, Richard Bergström, head of the European pharmaceutical industry body EFPIA, says the new arrangement makes sense but insists the federation did not and would not lobby for such a move1.
You may also be interested in...
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
EU trade expert Hervé Jouanjean considers the reasoning behind the EU’s vaccine procurement approach and Italy's decision to block exports of AstraZeneca's COVID-19 vaccine.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.